Fundraising Fox

Moat Biotechnology

Oklahoma City, US · Founded 2022 · Delaware LLC · 2 known investors

Biotech

Founders & leadership

RP
Russell P. RotherNamed on SEC filing
SA
Scott A. RollinsNamed on SEC filing
PJ
Philip JonesNamed on SEC filing
RA
Richard AlvarezNamed on SEC filing

Board

TFTodd Foley
Todd FoleyinBoard directorManaging Director at MPM BioImpact
MM
Michael Moradi-AraghiBoard director
PJ
Phillip JonesBoard director

Investors · 2

Cortado Venturesreported · 2 sourcesOklahoma City
MPM BioImpactreportedBoston · $1M – $15Mvia Todd Foley · board

Reported raises · per SEC filings

Form D private placements

$1.6M disclosed across 3 rounds · 2022–2025

▶$26.4KraisedOct 2025 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Russell P. RotherExecutive Officer, Director, Promoter
  • Tetherex Pharmaceuticals CorporationPromoter
  • Michael Moradi-AraghiDirector
  • Scott A. RollinsExecutive Officer, Director, Promoter
  • Todd FoleyDirector
  • Phillip JonesDirector
Offering amount
$15.6M
Amount sold
$26.4K
Minimum investment
$26.4K
Finders' fees
$800K
Proceeds to insiders
$4.5M
First sale
Oct 2025
Incorporated
Limited Liability Company, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$101.6KraisedFeb 2023 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Philip JonesDirector
  • Richard AlvarezExecutive Officer
  • Tetherex Pharmaceuticals CorporationPromoter
  • Russell RotherExecutive Officer, Director, Promoter
  • Scott A. RollinsExecutive Officer, Director, Promoter
  • Todd FoleyDirector
Offering amount
$20M
Amount sold
$101.6K
Minimum investment
$50.8K
Proceeds to insiders
$3.1M
First sale
Jan 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedOct 2022 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Philip JonesDirector
  • Tetherex Pharmaceuticals CorporationPromoter
  • Todd FoleyDirector
  • Richard AlvarezExecutive Officer
  • Scott RollinsExecutive Officer, Director, Promoter
  • Russell RotherExecutive Officer, Director, Promoter
Offering amount
$1.5M
Amount sold
$1.5M
Minimum investment
$250K
Proceeds to insiders
$1.5M
First sale
Jun 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Why We Invested: Moat Biotechnology | by Mike Moradi | Cortado Ventures Insights | Mediummedium.com · Oct 2023Moat reports initial Phase I data for intranasal Covid-19 vaccineclinicaltrialsarena.com · Sep 2022Moat Biotechnology Forms To Develop Novel Mucosal Vaccines for Covid-19 and Beyond: Announces Initial Funding Round and Promising Phase I trial results for Intranasal Covid-19 Vaccineprnewswire.com · Sep 2022

Frequently asked questions

Who are Moat Biotechnology's investors?
Moat Biotechnology's investors include Cortado Ventures, MPM BioImpact.
How much funding has Moat Biotechnology raised?
Moat Biotechnology has disclosed $1.6M raised across 3 rounds.
Where is Moat Biotechnology headquartered?
Moat Biotechnology is headquartered in Oklahoma City, US.